Shahlaa Zuhair Abdul-Majeed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shahlaa Zuhair Abdul-Majeed has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Shuhad Yaseen
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Rafidain University College, Baghdad 10052, Iraq
2 shared publications - Ashour H. Dawood
Al-Esraa University College, Baghdad, Iraq
1 shared publication - Jumana Suhban Sulaiman Almallah
Pharmacology Department, College of Pharmacy, Al-Bayan University, Baghdad, Iraq
1 shared publication Sarah Ashour Hamood
Biomedical Engineering Department, Engineering College, Al-Esraa University, Baghdad, Iraq
1 shared publication- Sarah Ashour Hamood
Biomedical Engineering Department, Al-Essra University College, Baghdad 10011, Iraq
1 shared publication
Latest Publications
- Open Access
- 23 July 2026
- Published by Hamad bin Khalifa University Press (HBKU Press) in Journal of Emergency Medicine, Trauma and Acute Care
- Vol. 2026 (3)
Synergistic Effects of Vitamin D And Omega-3 On Glycemic Regulation, Lipid Metabolism, and Oxidative Stress in Type-1 Diabetic Mice
Background: Vitamin D and omega-3 (ω-3) have garnered significant attention in the scientific community due to their ability to exert various non-classical activities on the body, and multifaceted roles in maintaining overall health. Hence, a good understanding of the potential effect of vitamin D and ω-3 in developing and progressing type-1 diabetes mellitus (T1DM) can assist in controlling clinical advancement of the disease. Aims: The current study aimed to experimentally induce T1DM to investigate the role of vitamin D, omega-3, and their combination on the activity of lipid profile, liver enzymes, and antioxidant markers. Materials and methods: A total of 75 young male mice were divided equally into five groups. Initially, T1DM was induced in PC, EG1, EG2, and EG3 by a single high dose of streptozotocin. Mice were treated daily with vitamin D (EG1), ω-3 (EG2), and a combination of both (EG3). After 12 weeks, mice were euthanized and blood was collected to be tested using quantitative specific ELISA kits for the measurement of different blood biomarkers. Results: In comparison to the values of PC, administration of vitamin D for mice of EG1 and ω-3 for mice of EG2 significantly lowered the levels of blood glucose, total cholesterol, LDL, triglyceride, ALT, AST, and MDA, as well as increasing the concentrations of HDL, catalase, GPX, and SOD. The highest ameliorative effect was shown in mice of EG3 that were administered a combination of vitamin D and ω-3. Conclusion: This study may represent the first study in Iraq that investigates the effect of vitamin D and ω-3 on the health status of T1DM in mice. However, the translation of these findings into clinical practice remains a challenge, underscoring the need for continued investigation to fully understand the multifaceted impact of vitamin D on human health.
- 23 July 2026
- Published by Hamad bin Khalifa University Press (HBKU Press) in Journal of Emergency Medicine, Trauma and Acute Care
- Vol. 2026 (3)
Open AccessSynergistic Effects of Vitamin D And Omega-3 On Glycemic Regulation, Lipid Metabolism, and Oxidative Stress in Type-1 Diabetic Mice
Background: Vitamin D and omega-3 (ω-3) have garnered significant attention in the scientific community due to their ability to exert various non-classical activities on the body, and multifaceted roles in maintaining overall health. Hence, a good understanding of the potential effect of vitamin D and ω-3 in developing and progressing type-1 diabetes mellitus (T1DM) can assist in controlling clinical advancement of the disease. Aims: The current study aimed to experimentally induce T1DM to investigate the role of vitamin D, omega-3, and their combination on the activity of lipid profile, liver enzymes, and antioxidant markers. Materials and methods: A total of 75 young male mice were divided equally into five groups. Initially, T1DM was induced in PC, EG1, EG2, and EG3 by a single high dose of streptozotocin. Mice were treated daily with vitamin D (EG1), ω-3 (EG2), and a combination of both (EG3). After 12 weeks, mice were euthanized and blood was collected to be tested using quantitative specific ELISA kits for the measurement of different blood biomarkers. Results: In comparison to the values of PC, administration of vitamin D for mice of EG1 and ω-3 for mice of EG2 significantly lowered the levels of blood glucose, total cholesterol, LDL, triglyceride, ALT, AST, and MDA, as well as increasing the concentrations of HDL, catalase, GPX, and SOD. The highest ameliorative effect was shown in mice of EG3 that were administered a combination of vitamin D and ω-3. Conclusion: This study may represent the first study in Iraq that investigates the effect of vitamin D and ω-3 on the health status of T1DM in mice. However, the translation of these findings into clinical practice remains a challenge, underscoring the need for continued investigation to fully understand the multifaceted impact of vitamin D on human health.
- Open Access
- 1 July 2024
- Published by Al-Rafidain University College in Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
- Vol. 7 (1) , 52-56
Design, Synthesis, Characterization and Preliminary Evaluation of New 1H-benzo[d]imidazole-1yl-derivatives as Acetylcholine Esterase Inhibitors
Background: Alzheimer disease (AD) is the most common type of dementia, which is still a problem that everyone must deal with. In a continuous effort to find effective treatments, the new candidates for AD therapy have the capacity to scavenge excessive levels of free radicals and inhibit acetylcholinesterase (AChE). Objectives: This study focuses on synthesizing and biologically evaluating novel hybrid compounds (1-3) as acetylcholine esterase inhibitors. Methods: The benzimidazole has been added and then coupled with coumaric acid, cinnamic acid, and lipoic acid as conjugates, which are expected to have dual action as acetylcholinesterase inhibitors and antioxidants. The synthesis of benzimidazole derivatives (1-3) was accomplished and then characterized using 1H-NMR and elemental analysis. Additionally, their characteristics were assessed in vitro against the AChE enzyme. Results: The new compounds produced a potent inhibitory activity that may serve as a lead molecule for the synthesis of novel anti-AD molecules. Compound-1 has an inhibition percentage that is close to that of the authorized medication galantamine (95.386%), whereas compound-3 has the lowest inhibition percentage (88.647%). Conclusions: A very good yield was achieved during the synthesis of the benzimidazole derivatives (1-3) from the starting material. They can serve as potential candidates for acetylcholine esterase inhibitors.
- 1 July 2024
- Published by Al-Rafidain University College in Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
- Vol. 7 (1) , 52-56
Open AccessDesign, Synthesis, Characterization and Preliminary Evaluation of New 1H-benzo[d]imidazole-1yl-derivatives as Acetylcholine Esterase Inhibitors
Background: Alzheimer disease (AD) is the most common type of dementia, which is still a problem that everyone must deal with. In a continuous effort to find effective treatments, the new candidates for AD therapy have the capacity to scavenge excessive levels of free radicals and inhibit acetylcholinesterase (AChE). Objectives: This study focuses on synthesizing and biologically evaluating novel hybrid compounds (1-3) as acetylcholine esterase inhibitors. Methods: The benzimidazole has been added and then coupled with coumaric acid, cinnamic acid, and lipoic acid as conjugates, which are expected to have dual action as acetylcholinesterase inhibitors and antioxidants. The synthesis of benzimidazole derivatives (1-3) was accomplished and then characterized using 1H-NMR and elemental analysis. Additionally, their characteristics were assessed in vitro against the AChE enzyme. Results: The new compounds produced a potent inhibitory activity that may serve as a lead molecule for the synthesis of novel anti-AD molecules. Compound-1 has an inhibition percentage that is close to that of the authorized medication galantamine (95.386%), whereas compound-3 has the lowest inhibition percentage (88.647%). Conclusions: A very good yield was achieved during the synthesis of the benzimidazole derivatives (1-3) from the starting material. They can serve as potential candidates for acetylcholine esterase inhibitors.
- 21 October 2022
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 15 (10) , 4377-4381
Studying the Anti-Cancer Activity of Resveratrol 1,3,4-Thiadiazol Derivatives
- 21 October 2022
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 15 (10) , 4377-4381
Studying the Anti-Cancer Activity of Resveratrol 1,3,4-Thiadiazol Derivatives